DURABILITY OF HBEAG SEROCONVERSION AFTER LAMIVUDINE MONOTHERAPY IN CONTROLLED PHASE-II AND PHASE-III TRIALS

Citation
E. Schiff et al., DURABILITY OF HBEAG SEROCONVERSION AFTER LAMIVUDINE MONOTHERAPY IN CONTROLLED PHASE-II AND PHASE-III TRIALS, Hepatology, 28(4), 1998, pp. 1-1
Citations number
NO
Language
INGLESE
art.tipo
Meeting Abstract
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
ISSN journal
0270-9139
Volume
28
Issue
4
Year of publication
1998
Part
2
Supplement
S
Pages
1 - 1
Database
ISI
SICI code
0270-9139(1998)28:4<1:DOHSAL>2.0.ZU;2-0